Abstract
AIDS Research and Human RetrovirusesVol. 30, No. S1 Cell and Tissue Models of ARVs for PreventionPredicting Effective Truvada® PrEP Dosing Strategies With a Novel PK-PD Model Incorporating Tissue Active Metabolites and Endogenous Nucleotides (EN)Mackenzie L. Cottrell, Kuo H. Yang, Heather M.A. Prince, Craig Sykes, Nicole White, Stephanie Malone, Evan S. Dellon, Ryan D. Madanick, Nicholas J. Shaheen, Julie A. Nelson, Ronald Swanstrom, Kristine B. Patterson, and Angela D.M. KashubaMackenzie L. CottrellUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this author, Kuo H. YangUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this author, Heather M.A. PrinceUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this author, Craig SykesUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this author, Nicole WhiteUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this author, Stephanie MaloneUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this author, Evan S. DellonUniversity of North Carolina School of Medicine, Chapel Hill, NC, United StatesSearch for more papers by this author, Ryan D. MadanickUniversity of North Carolina School of Medicine, Chapel Hill, NC, United StatesSearch for more papers by this author, Nicholas J. ShaheenUniversity of North Carolina School of Medicine, Chapel Hill, NC, United StatesSearch for more papers by this author, Julie A. NelsonUniversity of North Carolina Center for AIDS Research, Chapel Hill, NC, United StatesSearch for more papers by this author, Ronald SwanstromUniversity of North Carolina Center for AIDS Research, Chapel Hill, NC, United StatesSearch for more papers by this author, Kristine B. PattersonUniversity of North Carolina School of Medicine, Chapel Hill, NC, United StatesSearch for more papers by this author, and Angela D.M. KashubaUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, United StatesSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5107a.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Predicting Effective Truvada® PrEP Dosing Strategies With a Novel PK-PD Model Incorporating Tissue Active Metabolites and Endogenous Nucleotides (EN)." AIDS Research and Human Retroviruses, 30(S1), p. A60FiguresReferencesRelatedDetailsCited ByNondaily preexposure prophylaxis for HIV preventionCurrent Opinion in HIV and AIDS, Vol. 11, No. 1What people want from sex and preexposure prophylaxisCurrent Opinion in HIV and AIDS, Vol. 11, No. 1Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?2 November 2015 | Journal of the International AIDS Society, Vol. 18, No. 1 Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Mackenzie L. Cottrell, Kuo H. Yang, Heather M.A. Prince, Craig Sykes, Nicole White, Stephanie Malone, Evan S. Dellon, Ryan D. Madanick, Nicholas J. Shaheen, Julie A. Nelson, Ronald Swanstrom, Kristine B. Patterson, and Angela D.M. Kashuba.Predicting Effective Truvada® PrEP Dosing Strategies With a Novel PK-PD Model Incorporating Tissue Active Metabolites and Endogenous Nucleotides (EN).AIDS Research and Human Retroviruses.Oct 2014.A60-A60.http://doi.org/10.1089/aid.2014.5107a.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
